Literature DB >> 30592564

Methamphetamine presentations to an emergency department: Management and complications.

Katherine Z Isoardi1,2, Sarah F Ayles2, Keith Harris1,2, Clare J Finch1, Colin B Page1,2,3.   

Abstract

OBJECTIVE: There is little recent published data characterising methamphetamine intoxication. The present study aims to describe the clinical effects, management, complications and disposition of patients with methamphetamine exposure.
METHODS: This is a retrospective review of patients presenting with methamphetamine intoxication to an ED in 2016. All presentations were extracted from a relational database and each medical record reviewed. Demographics, clinical features, complications and disposition were extracted.
RESULTS: There were 378 presentations of 329 patients (234 men [71%]), median age 31 years (range 16-68 years). The most common clinical effect was acute behavioural disturbance, occurring in 295 (78%) presentations. This was successfully managed with oral sedation alone in 180 (61%) patients, with the remainder receiving parenteral sedation. Other effects included tachycardia in 212 (56%), hypertension in 160 (42%) and hyperthermia in 17 (5%) presentations. No anti-hypertensives were given. One patient was actively cooled. Complications included 21 (30%) presentations with rhabdomyolysis and 41 (13%) presentations with acute kidney injury. There were two seizures, three intracranial bleeds and one myocardial infarction. The majority (317 [84%]) of patients were managed solely within the ED. The median length of stay was 14 h. There were 41 (11%) mental health admissions. Two deaths occurred: one following an out-of-hospital cardiac arrest and the other a subarachnoid haemorrhage.
CONCLUSION: The main toxicity seen with methamphetamines is acute behavioural disturbance, which is managed well with sedation. Complications, apart from rhabdomyolysis and acute kidney injury, are rare. Most patients are managed within the ED and discharged home.
© 2018 Australasian College for Emergency Medicine.

Entities:  

Keywords:  acute behavioural disturbance; acute kidney injury; methamphetamine; rhabdomyolysis

Mesh:

Substances:

Year:  2018        PMID: 30592564     DOI: 10.1111/1742-6723.13219

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN: 1742-6723            Impact factor:   2.151


  7 in total

1.  Frequency of reported methamphetamine use linked to prevalence of clinical conditions, sexual risk behaviors, and social adversity in diverse men who have sex with men in Los Angeles.

Authors:  Steve Shoptaw; Michael J Li; Marjan Javanbakht; Amy Ragsdale; David Goodman-Meza; Pamina M Gorbach
Journal:  Drug Alcohol Depend       Date:  2022-01-19       Impact factor: 4.492

2.  Methamphetamine-induced lethal toxicity in zebrafish larvae.

Authors:  Yu Chen; Alexander S Wisner; Isaac T Schiefer; Frederick E Williams; F Scott Hall
Journal:  Psychopharmacology (Berl)       Date:  2022-10-21       Impact factor: 4.415

3.  Stimulant-related incident surveillance using emergency medical service records in Massachusetts, 2013-2020.

Authors:  Amy Bettano; Brandon Del Pozo; Dana Bernson; Joshua A Barocas
Journal:  Drug Alcohol Depend       Date:  2022-04-14       Impact factor: 4.852

4.  The Effect of Illegal Drug Screening Results and Chronic Drug Use on Perioperative Complications in Trauma.

Authors:  John T Culhane; Carl A Freeman
Journal:  J Emerg Trauma Shock       Date:  2020-12-07

Review 5.  Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

Authors:  Jolanta Weresa; Anna Pędzińska-Betiuk; Krzysztof Mińczuk; Barbara Malinowska; Eberhard Schlicker
Journal:  Cells       Date:  2022-03-28       Impact factor: 6.600

6.  "Complexity, safety and challenges: Emergency responders' experience of people affected by methamphetamines".

Authors:  Rikki Jones; Debra Jackson; Cindy Woods; Kim Usher
Journal:  Nurs Health Sci       Date:  2022-08-08       Impact factor: 2.214

Review 7.  Substance use among adolescents and young adults with chronic kidney disease or kidney failure.

Authors:  Nianzhou Xiao; Hua Chai; Abiodun Omoloja
Journal:  Pediatr Nephrol       Date:  2021-03-09       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.